LORUSSO, VITO
 Distribuzione geografica
Continente #
EU - Europa 199
NA - Nord America 113
AS - Asia 17
AF - Africa 1
Totale 330
Nazione #
SE - Svezia 171
US - Stati Uniti d'America 113
IT - Italia 15
SG - Singapore 6
IN - India 5
CN - Cina 4
DE - Germania 4
FI - Finlandia 4
ID - Indonesia 2
RO - Romania 2
CH - Svizzera 1
FR - Francia 1
IE - Irlanda 1
TG - Togo 1
Totale 330
Città #
Stockholm 154
Fairfield 29
Woodbridge 13
Ashburn 12
Cambridge 9
Chandler 7
Wilmington 7
Houston 5
Seattle 5
Helsinki 4
San Paolo di Civitate 4
Beijing 3
Princeton 3
Andover 2
Jakarta 2
Lawrence 2
Sacramento 2
Singapore 2
Boston 1
Bremen 1
Dearborn 1
Dublin 1
Guidonia 1
Kunming 1
Levallois-perret 1
Lomé 1
Millbury 1
Rome 1
San Diego 1
Santa Clara 1
Torino 1
Totale 278
Nome #
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 185
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 98
Time to first tumor progression as outcome predictor of a second trasuzumab-based therapy beyond progression in HER-2 positive metastatic breast cancer 69
Totale 352
Categoria #
all - tutte 743
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 743


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202062 0 0 0 2 10 9 8 10 8 7 7 1
2020/202120 8 0 2 3 0 1 0 0 0 5 0 1
2021/202240 0 0 1 4 11 4 0 3 4 2 5 6
2022/202339 10 10 1 2 9 2 3 0 1 1 0 0
2023/202421 1 3 2 2 2 1 0 3 0 7 0 0
2024/2025162 153 2 4 3 0 0 0 0 0 0 0 0
Totale 352